Field Trip Health and Henry Schein are competing in the healthcare technology market and listed on the Nasdaq stock exchange.
1 report, 1 independent
Updated Aug 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Field Trip Health and Henry Schein are competing in the healthcare technology market and listed on the Nasdaq stock exchange.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Henry Schein
American distributor of health care products and services
-
Nasdaq
American fully electronic stock exchange
Related events
- Jazz Pharmaceuticals and RYTHM are competing in the pharmaceutical market and listed on the Nasdaq stock exchange.
- Deloitte released a report discussing current trends within the healthcare market.
- Korro Bio, Inc. and Wellgistics Health were listed on the Nasdaq stock exchange on July 1, 2026.
- Argenex SE and Capricor Therapeutics were listed on the Nasdaq stock exchange and are competing in the biotech sector.
- Xenetic Biosciences and XTL Biopharmaceuticals are competing in the small-cap biopharmaceutical space, listed on the Nasdaq stock exchange.